Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.850
+0.250 (15.63%)
Aug 8, 2025, 4:08 PM HKT
Allakos Market Cap
Viva Biotech Holdings has a market cap or net worth of 3.90 billion as of August 8, 2025. Its market cap has increased by 264.31% in one year.
Market Cap
3.90B
Enterprise Value
4.28B
Revenue
2.11B
Ranking
n/a
PE Ratio
28.97
Stock Price
$1.85
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 3.90B, a decrease of -41.16%. That is a compound annual growth rate of -8.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 3.90B | 114.68% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | 17.49B | 145.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 257.63B |
| Hansoh Pharmaceutical Group Company | 210.01B |
| JD Health International | 165.77B |
| Innovent Biologics | 156.54B |
| Akeso | 141.28B |
| Sino Biopharmaceutical | 130.38B |
| WuXi Biologics | 122.16B |
| CSPC Pharmaceutical Group | 110.67B |